Skip to main content
. 2017 May 19;2017(5):CD011598. doi: 10.1002/14651858.CD011598.pub2

4.11. Analysis.

4.11

Comparison 4 Serious adverse event maximum follow‐up, Outcome 11 Serious adverse events ‐ trials where the intervention lasts fewer than three days compared with trials where the intervention lasts three days or more.